GLP1 Products

Antibodies
GLP1 Antibody (970307) [Uncon ...
GLP1 Antibody (970307) [Unconjugated]
MAB12491
Species: Hu
Applications: IHC
Host: Mouse Monoclonal
Formulation Catalog # Availability Price  
GLP1 Antibody (2622B) [Unconj ...
GLP1 Antibody (2622B) [Unconjugated]
MAB10473
Species: Hu
Applications: IHC
Host: Rabbit Monoclonal
Formulation Catalog # Availability Price  
ELISA Kits
Rat GLP1 ELISA Kit (Colorimet ...
Rat GLP1 ELISA Kit (Colorimetric)
NBP3-18781
Species: Rt
Applications: ELISA, S-ELISA
Human GLP1 ELISA Kit (Colorim ...
Human GLP1 ELISA Kit (Colorimetric)
NBP3-12819
Species: Hu
Applications: ELISA
Mouse GLP1 ELISA Kit (Colorim ...
Mouse GLP1 ELISA Kit (Colorimetric)
NBP3-18782
Species: Mu
Applications: ELISA, S-ELISA

Description

Glucagon-like peptide-1 (GLP-1) is an incretin hormone secreted from enteroendocrine L cells in response to ingested nutrients. The closely related peptides glucagon-like peptide (GLP-1) and glucagon have opposing effects on blood glucose. GLP-1 induces glucose-dependent insulin secretion in the pancreas, while glucagon stimulates gluconeogenesis and glycogenolysis in the liver. Glucagon is processed from a large precursor, proglucagon, in a tissue-specific manner in pancreatic alpha-cells. The identification of a hybrid peptide acting as both a GLP-1 agonist and a glucagon antagonist would provide a novel approach for the treatment of type 2 diabetes.

Bioinformatics

Entrez Human
Human
Uniprot Human
Human
Product By Gene ID 2641
Alternate Names
  • glicentin-related polypeptide
  • GLP1
  • glucagon-like peptide 1
  • GRPP

Research Areas for GLP1

Find related products by research area and learn more about each of the different research areas below.

Cancer
GPCR
Signal Transduction

PTMs for GLP1

Learn more about PTMs related to GLP1.

Phosphorylation
Cleavage

Bioinformatics Tool for GLP1

Discover related pathways, diseases and genes to GLP1. Need help? Read the Bioinformatics Tool Guide for instructions on using this tool.
 
Vizit™, under license from BioVista Inc.